Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thomas Tritz"'
Autor:
Laurene Deconinck, Aurélien Dinh, Christophe Nich, Thomas Tritz, Morgan Matt, Olivia Senard, Simon Bessis, Thomas Bauer, Martin Rottman, Jérome Salomon, Frédérique Bouchand, Benjamin Davido
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0224106 (2019)
INTRODUCTION:Cotrimoxazole (Sulfamethoxazole-Trimethoprim, SXT) has interesting characteristics for the treatment of bone and joint infection (BJI): a broad spectrum of activity with adequate bone diffusion and oral and intravenous formulations. Howe
Externí odkaz:
https://doaj.org/article/8298a354f3e2435bb92233e29ecc9e04
Autor:
Frédérique Bouchand, Benjamin Davido, Morgan Matt, Olivia Senard, Jérôme Salomon, Julie Attal, Alain Beauchet, Caroline Guyot, Anne-Sophie Levasseur, Laurène Deconinck, Clara Duran, Thomas Tritz, Aurélien Dinh, David Razazi, Julie Grenet, Sébastien Beaune
Publikováno v:
The Journal of hospital infection. 97(3)
Antimicrobial stewardship programmes (ASPs) have been effective in optimizing antibiotic use for inpatients. However, an emergency department's fast-paced clinical setting can be challenging for a successful ASP.In April 2015, an ASP was implemented
Autor:
Christophe Nich, Jérôme Salomon, Benjamin Davido, Olivia Senard, Martin Rottman, Simon Bessis, Morgan Matt, Frédérique Bouchand, Thomas Tritz, Thomas W. Bauer, Aurélien Dinh, Laurène Deconinck
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 10, p e0224106 (2019)
PLoS ONE, Vol 14, Iss 10, p e0224106 (2019)
Introduction Cotrimoxazole (Sulfamethoxazole-Trimethoprim, SXT) has interesting characteristics for the treatment of bone and joint infection (BJI): a broad spectrum of activity with adequate bone diffusion and oral and intravenous formulations. Howe
Autor:
Thomas Hanslik, Cécile Souty, Solen Kernéis, Thierry Blanchon, Bruno Lambert, Agnes Lillo-Le-Louet, Thomas Tritz, Clément Turbelin, Christophe Arena, Victoire Roussel
Publikováno v:
Pharmacoepidemiology and Drug Safety. 22:1080-1085
Purpose Anti-dopaminergic anti-emetics (ADA) use for the treatment of nausea associated with gastroenteritis (GE) can be considered inappropriate, as their effects are not supported by evidence of clinical efficacy and can potentially induce serious